ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

156 Afleveringen

1. ACCEL Lite: Pre-Eclampsia: Maternal Red Flag of Risk

   Gepubliceerd: 14-7-2022
2. ACCEL Lite: Black Maternal Health: A Call to Action and Implications for Prevention

   Gepubliceerd: 13-7-2022
3. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Return to Play

   Gepubliceerd: 5-7-2022
4. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Post-acute Sequelae

   Gepubliceerd: 28-6-2022
5. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Myocarditis

   Gepubliceerd: 21-6-2022
6. ACCEL Lite: Inflamed! Populations at Risk for Inflammation Associated CVD

   Gepubliceerd: 14-6-2022
7. ACCEL Lite: Significant Updates from the 2021 ACC Coronary Artery Revascularization Guidelines

   Gepubliceerd: 7-6-2022
8. ACCEL Lite: ACC.22 Late Breaker: ADAPT-TAVR Trial - Edoxaban Versus DAPT For Valve Thrombosis And Cerebral TE After TAVR

   Gepubliceerd: 24-5-2022
9. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

   Gepubliceerd: 17-5-2022
10. ACCEL Lite: ACC.22 Late Breaker: CHAP RCT -- Antihypertensive Therapy For Mild Chronic Hypertension Improves Pregnancy Outcomes

    Gepubliceerd: 10-5-2022
11. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

    Gepubliceerd: 3-5-2022
12. ACCEL Lite: Late Breaker: Mavacamten as an Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Gepubliceerd: 26-4-2022
13. ACCEL Lite: Late Breaker: SODIUM-HF: Dietary Intervention Under 100 Mmol In Heart Failure

    Gepubliceerd: 19-4-2022
14. ACCEL Lite: Late Breaker: METEORIC-HF: The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic HFrEF

    Gepubliceerd: 12-4-2022
15. ACCEL Lite: Late Breaker: DIAMOND trial: Patiromer For The Management Of Hyperkalemia In Subjects Receiving Renin-angiotensin-aldosterone System Inhibitor Medications For HFrEF

    Gepubliceerd: 5-4-2022
16. ACCEL Lite: Screening for Transthretin Amyloid Cardiomyopathy in Everyday Practice

    Gepubliceerd: 22-3-2022
17. ACCEL Lite: When Is Genetic Testing Helpful?

    Gepubliceerd: 15-3-2022
18. ACCEL Lite: Special Considerations in Screening of Masters Athletes with CAD

    Gepubliceerd: 8-3-2022
19. ACCEL Lite: Helping Patients Improve Lifestyle Behavior in the Digital Era

    Gepubliceerd: 1-3-2022
20. ACCEL Lite: Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis--Focus on AL

    Gepubliceerd: 22-2-2022